BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1945790)

  • 1. [Immunohistochemical study of fibronectin expression in cancer tissue before and after irradiation].
    Nishioka A; Ogawa Y; Inomata T; Maeda T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Sep; 51(9):1087-97. PubMed ID: 1945790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin expression in cancer tissues from patients undergoing radiation therapy.
    Nishioka A; Ogawa Y; Inomata T; Maeda T; Seguchi H
    Histol Histopathol; 1993 Jul; 8(3):457-62. PubMed ID: 8358157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of the immunohistochemical method as predictive assay in radiotherapy of squamous cell carcinoma].
    Ogawa Y; Inomata T; Maeda T; Seguchi H; Nishioka A; Terashima M; Kishimoto S; Saito H; Hirota S; Osaki T
    Gan No Rinsho; 1988 Oct; 34(13):1799-810. PubMed ID: 3264351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of fibronectin expression in cancer tissue exposed to irradiation.
    Nishioka A; Ogawa Y; Terashima M; Inomata T; Yoshida S; Maeda T; Seguchi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Nov; 50(11):1454-6. PubMed ID: 2087406
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of p53 expression in cancer tissues from patients undergoing radiation therapy.
    Hamada N; Ogawa Y; Seguchi H; Terashima M; Nishioka A; Inomata T; Yoshida S; Kishimoto S; Saito H
    Histol Histopathol; 1995 Jul; 10(3):611-7. PubMed ID: 7579809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
    Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
    Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
    Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative irradiation for head and neck cancer: results of a prospective study.
    Terz JJ; King ER; Lawrence W
    Surgery; 1981 Apr; 89(4):449-53. PubMed ID: 7010651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
    Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
    Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
    Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
    Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.